share_log

The Oncology Institute, Inc. (NASDAQ:TOIIW) COO Matthew P. Miller Buys 73,684 Shares of Stock

Defense World ·  Dec 21, 2022 06:31

The Oncology Institute, Inc. (NASDAQ:TOIIW – Get Rating) COO Matthew P. Miller bought 73,684 shares of Oncology Institute stock in a transaction on Friday, December 16th. The stock was acquired at an average cost of $0.95 per share, with a total value of $69,999.80. Following the acquisition, the chief operating officer now owns 175,325 shares in the company, valued at approximately $166,558.75. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Oncology Institute Stock Performance

TOIIW stock opened at $0.06 on Wednesday. The Oncology Institute, Inc. has a 1 year low of $0.06 and a 1 year high of $1.50. The stock's fifty day moving average price is $0.32 and its 200-day moving average price is $0.56.

Get Oncology Institute alerts:

Hedge Funds Weigh In On Oncology Institute

A hedge fund recently raised its stake in Oncology Institute stock. Wolverine Asset Management LLC boosted its stake in shares of The Oncology Institute, Inc. (NASDAQ:TOIIW – Get Rating) by 29.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 118,666 shares of the company's stock after acquiring an additional 26,700 shares during the quarter. Wolverine Asset Management LLC's holdings in Oncology Institute were worth $59,000 as of its most recent SEC filing.

About Oncology Institute

(Get Rating)

The Oncology Institute, Inc, an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants for cancer patients.

Recommended Stories

  • Get a free copy of the StockNews.com research report on Oncology Institute (TOIIW)
  • Is There a Prize in Store for Kellogg Shareholders?
  • Will AMC's Troubles Affect Its Landlord, EPR Properties?
  • General Mills Retreats To More Attractive Territory
  • Will Tesla Shares Rally If Musk Steps Down From Twitter?
  • 5 Down But Not Out Stocks To Watch For 2023

Receive News & Ratings for Oncology Institute Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncology Institute and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment